Terumo (OTCMKTS:TRUMY) Share Price Crosses Below 50-Day Moving Average - What's Next?

Key Points

• Technical signal: Terumo's share price slipped below its 50-day moving average of $13.16, trading as low as $12.66 and last at $12.69 on volume of 304,336, indicating short-term weakness versus the 50‑day trend.
• Mixed quarterly results: The company reported $0.14 EPS (missed $0.15 consensus) while revenue beat at $1.94B versus $1.82B, showing earnings slightly lagging but top-line strength.
• Neutral analyst view and valuation: The stock carries a consensus rating of "Hold," with a market cap of $18.72B, P/E of 21.88 and low debt-to-equity (0.07), reflecting cautious sentiment and a reasonable valuation.

Terumo Corp. (OTCMKTS:TRUMY - Get Free Report)'s stock price passed below its 50-day moving average during trading on Tuesday . The stock has a 50-day moving average of $13.16 and traded as low as $12.66. Terumo shares last traded at $12.69, with a volume of 304,336 shares changing hands.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Zacks Research raised shares of Terumo to a "hold" rating in a research report on Thursday, April 9th. Nomura upgraded shares of Terumo to a "hold" rating in a research report on Tuesday, February 24th. Two equities research analysts have rated the stock with a Hold rating, According to MarketBeat, the stock has a consensus rating of "Hold".

Terumo Stock Up 0.6%

The company has a market capitalization of $18.72 billion, a P/E ratio of 21.88 and a beta of 0.72. The company has a 50-day moving average of $13.16 and a two-hundred day moving average of $14.30. The company has a quick ratio of 0.89, a current ratio of 1.51 and a debt-to-equity ratio of 0.07.

Terumo (OTCMKTS:TRUMY - Get Free Report) last posted its quarterly earnings data on Friday, February 13th. The company reported $0.14 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.15 by ($0.01). The firm had revenue of $1.94 billion during the quarter, compared to the consensus estimate of $1.82 billion. Terumo had a return on equity of 9.01% and a net margin of 11.74%. On average, research analysts predict that Terumo Corp. will post 0.58 EPS for the current year.

About Terumo

Terumo Corporation OTCMKTS: TRUMY is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.